��������

Dr. Sarah Teichmann did her PhD at the MRC Laboratory of Molecular Biology, Cambridge, UK and was a Beit Memorial Fellow at University College London. She started a group at the MRC Laboratory of Molecular Biology in 2001. In 2013, she moved to the Wellcome Genome Campus in Hinxton, Cambridge, where her group was joint between the EMBL-European Bioinformatics Institute and the Wellcome Sanger Institute. Dr. teichmann is an EMBO member and fellow of the Academy of Medical Sciences, and her work has been recognized by a number of prizes, including the Lister Prize, Biochemical Society Colworth Medal, Royal Society Crick Lecture and EMBO Gold Medal. From 2016, she is the Head of Cellular Genetics at the Wellcome Sanger Institute and a visiting research group leader at the European Bioinformatics Institute (EMBL-EBI). She serves as director of research (equivalent to Professor) in the Cavendish Laboratory [en.wikipedia.org] at the University of Cambridge and a senior research fellow at Churchill College, Cambridge.

Dr. Teichmann is interested in global principles of protein interactions and gene expression. Her team uses single-cell approaches, so called “cell atlas” technologies, combined with human genetics at the cellular level. for further understanding of human health, development and disease.